This financing validates the considerable technical breakthroughs achieved by QuEra in collaboration with Mikhail Lukin, Markus Greiner, and their teams at Harvard, as well as Vladan Vuletic and his ...
QuEra Computing, a neutral-atom quantum computing, today announced it has successfully completed a financing of more than ...
Cheol's team at KERI's Next Generation Battery Research Center has developed an "enhanced coprecipitation method" that ...
Opinion
1dOpinion
Zacks.com on MSNTop Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillipsThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Boston ...
As usual, the mysteries of the cosmos will be on display at this year’s fest, beginning with opening-night film "Small Town ...
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...
This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...
Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...
Cognitively normal human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results